Marinus Pharmaceuticals reported $-23823000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Aptinyx Inc APTX:US $ -19819000 5.59M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Biogen BIIB:US $ 814.2M 255M
Eisai 4523:JP Y 55783M 61588M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Minerva Neurosciences NERV:US $ -10.59M 3.08M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Supernus Pharmaceuticals SUPN:US $ 31.24M 20.31M
YTE INCY:US $ 199.6M 31.06M
Zogenix ZGNX:US $ -58.9M 3.27M